Shalev and colleagues found that mice with a targeted deletion of FGL2 as well as wild-type mice reconstituted with FGL2−/− bone marrow developed autoimmune glomerulonephritis with increasing age [18]. This evidence concerns the gene FGL2 and autoimmune glomerulonephritis.